Congressman Scott Peters Tours Maravai’s RNA manufacturing facility
June 06, 2023 08:00 ET
|
Maravai LifeSciences Holdings LLC
SAN DIEGO, June 06, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, recently hosted...
TriLink BioTechnologies Introduces Latest mRNA Capping Technology: CleanCap® M6 analog
May 09, 2023 08:00 ET
|
Maravai LifeSciences Holdings LLC
SAN DIEGO, May 09, 2023 (GLOBE NEWSWIRE) -- TriLink BioTechnologies (TriLink), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has launched...
Maravai LifeSciences Reports First Quarter 2023 Financial Results
May 08, 2023 16:05 ET
|
Maravai LifeSciences Holdings LLC
SAN DIEGO, May 08, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech...
Maravai LifeSciences To Host Earnings Conference Call on Monday, May 8, 2023
April 17, 2023 16:15 ET
|
Maravai LifeSciences Holdings LLC
SAN DIEGO, April 17, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators,...
Maravai LifeSciences Releases 2022 Environmental, Social and Governance (ESG) Report
March 28, 2023 17:00 ET
|
Maravai LifeSciences Holdings LLC
- Highlights progress across five priority areas focused on building a foundation for sustainable growth. - Reports Scope 1 and Scope 2 greenhouse gas emissions. - Maravai advances Diversity, Equity...
Maravai LifeSciences Announces March 2023 Investor Conference Schedule
March 08, 2023 08:00 ET
|
Maravai LifeSciences Holdings LLC
SAN DIEGO, March 08, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled...
Maravai LifeSciences Reports Fourth Quarter and Full Year 2022 Financial Results
February 22, 2023 16:05 ET
|
Maravai LifeSciences Holdings LLC
Base business revenues, excluding COVID-19 related CleanCap® revenues, were up 67% in the fourth quarter and up 17% for the full year Announces acquisition of privately-held Alphazyme, LLC, adding...
Maravai LifeSciences to Host Earnings Conference Call on Wednesday, February 22, 2023
February 01, 2023 08:00 ET
|
Maravai LifeSciences Holdings LLC
SAN DIEGO, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans...
Maravai LifeSciences Announces Updated CEO Leadership Transition Plans
December 01, 2022 16:01 ET
|
Maravai LifeSciences Holdings LLC
Maravai announces plans for William “Trey” Martin, III to serve as President of its Biologics Safety Testing Segment and its expectation that he will then assume the role of Maravai’s CEO in July 2023...
Maravai LifeSciences Named to the 2022 Deloitte Technology Fast 500™ List of Fastest-Growing Companies in North America
November 16, 2022 17:05 ET
|
Maravai LifeSciences Holdings LLC
SAN DIEGO, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced...